FCCC LOGO Faculty Publications
Benson AB 3rd , Venook AP , Bekaii-Saab T , Chan E , Chen YJ , Cooper HS , Engstrom PF , Enzinger PC , Fenton MJ , Fuchs CS , Grem JL , Grothey A , Hochster HS , Hunt S , Kamel A , Kirilcuk N , Leong LA , Lin E , Messersmith WA , Mulcahy MF , Murphy JD , Nurkin S , Rohren E , Ryan DP , Saltz L , Sharma S , Shibata D , Skibber JM , Sofocleous CT , Stoffel EM , Stotsky-Himelfarb E , Willett CG , Gregory KM , Freedman-Cass D
Rectal Cancer, Version 2.2015
J Natl Compr Canc Netw. 2015 Jun;13(6) :719-28
PMID: 26085388   
Back to previous list
The NCCN Guidelines for Rectal Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Rectal Cancer Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize major discussion points from the 2015 NCCN Rectal Cancer Panel meeting. Major discussion topics this year were perioperative therapy options and surveillance for patients with stage I through III disease.
Benson, Al B 3rd Venook, Alan P Bekaii-Saab, Tanios Chan, Emily Chen, Yi-Jen Cooper, Harry S Engstrom, Paul F Enzinger, Peter C Fenton, Moon J Fuchs, Charles S Grem, Jean L Grothey, Axel Hochster, Howard S Hunt, Steven Kamel, Ahmed Kirilcuk, Natalie Leong, Lucille A Lin, Edward Messersmith, Wells A Mulcahy, Mary F Murphy, James D Nurkin, Steven Rohren, Eric Ryan, David P Saltz, Leonard Sharma, Sunil Shibata, David Skibber, John M Sofocleous, Constantinos T Stoffel, Elena M Stotsky-Himelfarb, Eden Willett, Christopher G Gregory, Kristina M Freedman-Cass, Deborah United States J Natl Compr Canc Netw. 2015 Jun;13(6):719-28.